Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

JDRF partners with Pfizer's CTI to support diabetes research

JDRF, the leading global organization funding type 1 diabetes research, announced today a partnership with Pfizer's Centers for Therapeutic Innovation to support the development and translation of promising diabetes research.

4 Nov 2013

GeNeuro's GNbAC1 antibody demonstrates safety profile in Phase 2a study for MS

GeNeuro announced today that its GNbAC1 humanized monoclonal antibody was found to have a very good safety profile when administered to patients with relapsing and progressive forms of Multiple Sclerosis as part of a Phase 2a study.

4 Nov 2013

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is urging employers to identify and respond to the impact of diabetes on worker health and productivity.

4 Nov 2013

McMaster University researchers discover how metformin drug works on fat in the liver

About 120 million people around the world with Type 2 diabetes - and two million in Canada - take the drug metformin to control their disease.

4 Nov 2013

New therapeutic approach for treating type 2 diabetes

Scientists from the Helmholtz Zentrum München (HMGU) and the Technische Universität München (TUM), together with scientists in the USA, have developed a new therapeutic approach for treatment of type 2 diabetes.

31 Oct 2013

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today reported preliminary data from the Company's ongoing extension study of a Phase I/II clinical trial with its lead product Glassia® to treat pediatric patients with a recently diagnosed type 1 diabetes (T1D).

31 Oct 2013

Scientists explain genetic and molecular basis of diabetes

In two comprehensive studies, scientists from Helmholtz Zentrum München, Ludwig-Maximilians-Universität München and Technische Universität München discovered new associations of two major type 2 diabetes risk genotypes and altered plasma concentrations of metabolic products.

31 Oct 2013

"Good" cholesterol improves blood glucose levels, say scientists

High density lipoprotein cholesterol (HDL), the so-called "good" cholesterol improves blood glucose levels by enhancing skeletal muscle function and reducing adiposity, scientists of the Helmholtz Zentrum München report in the current issue of the renown American Heart Association Journal ‚Circulation'.

31 Oct 2013

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Scientists from the Helmholtz Zentrum Muenchen and the Technische Universitaet Muenchen, together with scientists in the USA, have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.

31 Oct 2013

Honey may be detrimental for patients with type 2 diabetes

Honey may be detrimental for patients with type 2 diabetes because of the great quantities of sugars it contains.

31 Oct 2013

Study: Glucose levels, vascular damage contribute to dementia

High blood-sugar levels, such as those linked with Type 2 diabetes, make beta amyloid protein associated with Alzheimer's disease dramatically more toxic to cells lining blood vessels in the brain, according to a new Tulane University study published in latest issue of the Journal of Alzheimer's Disease.

29 Oct 2013

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics Conference in San Francisco.

29 Oct 2013

Scientist wins first Harold Hamm International Prize for Biomedical Research in Diabetes

Imagine how different the lives of so many would be if diabetes were cured and the billions of dollars in annual health care costs that could be saved.

29 Oct 2013

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Healthy weight: The key to a healthy heart

A healthy weight is the key to a healthy heart, and yet an estimated 1 out of 3 children is either overweight or obese in the U.S. During a special symposium Oct. 27 at the American Academy of Pediatrics National Conference and Exhibition in Orlando, pediatricians discussed obesity and cardiovascular risk factors, public health policy, and how physicians can partner with families to improve children's weight.

28 Oct 2013

Researchers study genetic factors associated to metabolic syndrome

Researchers from the Institute of Genomic Medicine carried out a study on genetic factors that can be associated to metabolic syndrome, main trigger of cardiovascular diseases, type II diabetes and obesity, with the goal of identifying high risk populations and influence its treatment in the most effective way.

25 Oct 2013

Diabetic patients may require higher doses of metformin to achieve same anti-cancer activity

A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.

25 Oct 2013

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

JDRF partners with Pfizer's CTI to support diabetes research

GeNeuro's GNbAC1 antibody demonstrates safety profile in Phase 2a study for MS

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

McMaster University researchers discover how metformin drug works on fat in the liver

New therapeutic approach for treating type 2 diabetes

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Scientists explain genetic and molecular basis of diabetes

"Good" cholesterol improves blood glucose levels, say scientists

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Honey may be detrimental for patients with type 2 diabetes

Study: Glucose levels, vascular damage contribute to dementia

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

Scientist wins first Harold Hamm International Prize for Biomedical Research in Diabetes

DPP-4 inhibitors may reduce risk of autoimmune diseases

Healthy weight: The key to a healthy heart

Researchers study genetic factors associated to metabolic syndrome

Diabetic patients may require higher doses of metformin to achieve same anti-cancer activity

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

Researchers discover novel genetic cause of severe obesity

Biolinerx Inks In-License Agreement With Israeli Institutions For Type 1 Diabetes Treatment

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in